ArticleThe American journal of case reports2026
Bilateral Cochlear Implantation in a Child With Galloway-Mowat Syndrome: A Case Report.
Article in The American journal of case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND This report describes the surgical management and early auditory outcomes of bilateral cochlear implantation in a child with Galloway-Mowat syndrome (GAMOS). To the best of our knowledge, this is the first reported case of such surgery. GAMOS is an exceedingly rare genetic disorder characterized by microcephaly, early onset of steroid-resistant nephrotic syndrome, and brain anomalies. It is inherited in an autosomal recessive pattern and has a genetically heterogeneous basis. CASE REPORT We report the case of a young boy diagnosed with GAMOS who had profound bilateral deafness, cerebellar hypoplasia, hypotonia, epilepsy, and visual impairment likely due to optic nerve dysgenesis. Due to the deafness, he underwent bilateral cochlear implantation in 2 stages (at ages 2 and 3 years). No significant difficulties were encountered: appropriate surgical access was achieved despite partial bony overgrowth of the round window area, and soft electrodes were used to adapt to the dysplastic cochlear anatomy. Ethics committee approval was obtained and written informed parental consent was provided. Preliminary results at 6 months after the second implant were satisfactory. As a result of the cochlear implantation, the boy was able to perceive sounds and began using them to communicate with those around him. CONCLUSIONS Cochlear implantation can be a safe and effective solution for treating deafness in patients with GAMOS, at least in the short term, even if there are congenital defects such as cochlear dysplasia. Good surgical access and the use of soft electrodes are important in minimizing the risk of damage and maximizing auditory outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.